Targeting PKMYT1 Kinase as a Therapeutic Strategy for Treatment of Triple Negative Breast Cancer with Low Molecular Weight Cyclin E (LMW-E) Expression

被引：0
|
作者：
Li, Mi
Lulla, Amriti
Karakas, Cansu
Tsavaschidis, Spiridon
Wang, Yan
Nguyun, Tuyen
Bui, Tuyen
Marshall, Gary
Hunt, Kelly
Keyomarsi, Khandan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO1-16-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO1-16-04
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting PKMYT1 kinase is an effective treatment strategy in triple negative breast cancers with low molecular weight cyclin E (LMW-E) expression
    Lulla, Amriti
    Nguyen, Tuyen D.
    Li, Mi
    Mastoraki, Sofia
    Wang, Yan
    Tuyen Bui
    Pina, Marc
    Tsavachidis, Spiridon
    Marshall, Gary
    Hunt, Kelly K.
    Keyomarsi, Khandan
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Targeting low molecular weight cyclin E (LMW-E) in breast cancer
    Nanos-Webb, Angela
    Jabbour, Natalie A.
    Multani, Asha S.
    Wingate, Hannah
    Oumata, Nassima
    Galons, Herve
    Joseph, Benoit
    Meijer, Laurent
    Hunt, Kelly K.
    Keyomarsi, Khandan
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (02) : 575 - 588
  • [3] Targeting low molecular weight cyclin E (LMW-E) in breast cancer
    Angela Nanos-Webb
    Natalie A. Jabbour
    Asha S. Multani
    Hannah Wingate
    Nassima Oumata
    Hervé Galons
    Benoît Joseph
    Laurent Meijer
    Kelly K. Hunt
    Khandan Keyomarsi
    Breast Cancer Research and Treatment, 2012, 132 : 575 - 588
  • [4] Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer
    Li, Mi
    Lulla, Amriti R.
    Wang, Yan
    Tsavaschidis, Spyros
    Wang, Fuchenchu
    Karakas, Cansu
    Nguyen, Tuyen D. T.
    Bui, Tuyen N.
    Pina, Marc A.
    Chen, Mei-Kuang
    Mastoraki, Sofia
    Multani, Asha S.
    Fowlkes, Natalie W.
    Sahin, Aysegul
    Marshall, C. Gary
    Hunt, Kelly K.
    Keyomarsi, Khandan
    CANCER RESEARCH, 2024, 84 (22) : 3864 - 3880
  • [5] Targeting low molecular weight (LMW) cyclin E-Cdk2 pathway for the prevention of breast cancer
    Akli, Said
    Yang, Dong
    Bui, Tuyen N.
    Keyomarsi, Khandan
    CANCER RESEARCH, 2015, 75
  • [6] BRCA1/2 Status and Low Molecular Weight Cyclin E (LMWE) Expression in Triple Negative Breast Cancer (TNBC) as a Function of Race and Survival
    Adjapong, Opoku
    Keyomarsi, Khandan
    Yi, Min
    Karakas, Cansu
    MODERN PATHOLOGY, 2015, 28 : 32A - 32A
  • [7] BRCA1/2 Status and Low Molecular Weight Cyclin E (LMWE) Expression in Triple Negative Breast Cancer (TNBC) as a Function of Race and Survival
    Adjapong, Opoku
    Keyomarsi, Khandan
    Yi, Min
    Karakas, Cansu
    LABORATORY INVESTIGATION, 2015, 95 : 32A - 32A
  • [8] Low molecular weight (LMW) Cyclin E bypass the aromatase inhibitors induced G1 arrest in human breast cancer cells
    Alin, Said
    Bui, Tuyen
    Keyomarsi, Khandan
    CANCER RESEARCH, 2009, 69
  • [9] Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer
    Spruck, Charles
    Sun, Dahui
    Fiegl, Heidi
    Marth, Christian
    Mueller-Holzner, Elisabeth
    Goebel, Georg
    Widschwendter, Martin
    Reed, Steven I.
    CANCER RESEARCH, 2006, 66 (14) : 7355 - 7360
  • [10] Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition
    Chen, Xian
    Low, Kwang-Huei
    Alexander, Angela
    Jiang, Yufeng
    Karakas, Cansu
    Hess, Kenneth R.
    Carey, Jason P. W.
    Bui, Tuyen N.
    Vijayaraghavan, Smruthi
    Evans, Kurt W.
    Yi, Min
    Ellis, D. Christian
    Cheung, Kwok-Leung
    Ellis, Ian O.
    Fu, Siqing
    Meric-Bernstam, Funda
    Hunt, Kelly K.
    Keyomarsi, Khandan
    CLINICAL CANCER RESEARCH, 2018, 24 (24) : 6594 - 6610
12345